JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

Search

Thermo Fisher Scientific Inc

Gesloten

SectorGezondheidszorg

558.41 0.1

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

553.91

Max

571.44

Belangrijke statistieken

By Trading Economics

Inkomsten

100M

1.6B

Verkoop

491M

11B

K/W

Sectorgemiddelde

31.148

37.461

Dividendrendement

0.3

Winstmarge

14.878

Werknemers

125,000

EBITDA

1.1B

2.8B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+10.37% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.30%

2.33%

Volgende Ex Dividend datum

12 dec 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

52B

205B

Vorige openingsprijs

558.31

Vorige sluitingsprijs

558.41

Nieuwssentiment

By Acuity

29%

71%

74 / 373 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Thermo Fisher Scientific Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 okt 2025, 20:49 UTC

Winsten

Correction to Thermo Fisher Article on Oct. 22

22 okt 2025, 10:28 UTC

Winsten

Thermo Fisher 3Q Revenue Rises, Boosted by Life Sciences Business

23 jul 2025, 10:33 UTC

Winsten

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25 jun 2025, 21:19 UTC

Acquisities, Fusies, Overnames

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

28 mei 2025, 14:02 UTC

Acquisities, Fusies, Overnames

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

23 apr 2025, 10:33 UTC

Winsten

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

22 okt 2025, 10:01 UTC

Winsten

Thermo Fisher 3Q Organic Revenue Rose 3% >TMO

22 okt 2025, 10:00 UTC

Winsten

Thermo Fisher: In Great Position to Deliver on 2025 Objectives >TMO

22 okt 2025, 10:00 UTC

Winsten

Thermo Fisher 3Q Adj EPS $5.79 >TMO

22 okt 2025, 10:00 UTC

Winsten

Thermo Fisher 3Q Rev $11.12B >TMO

22 okt 2025, 10:00 UTC

Winsten

Thermo Fisher 3Q Net $1.62B >TMO

22 okt 2025, 10:00 UTC

Winsten

Thermo Fisher 3Q EPS $4.27 >TMO

2 sep 2025, 12:15 UTC

Acquisities, Fusies, Overnames

Thermo Fisher Scientific Completes Acquisition Of Sanofi's Ridgefield, New Jersey Site >TMO

2 sep 2025, 12:08 UTC

Acquisities, Fusies, Overnames

Solventum Had Seen 2025 Adjusted EPS $5.80-$5.95 >SOLV

2 sep 2025, 12:08 UTC

Acquisities, Fusies, Overnames

Solventum Raises 2025 View To Adj EPS $5.88-Adj EPS $6.03 >SOLV

2 sep 2025, 12:04 UTC

Acquisities, Fusies, Overnames

Solventum to Use Net Proceeds Primarily to Pay Down Debt >SOLV

2 sep 2025, 12:03 UTC

Acquisities, Fusies, Overnames

Solventum Closes Sale of Unit to Thermo Fisher for $4 Billion in Cash >SOLV

2 sep 2025, 12:03 UTC

Acquisities, Fusies, Overnames

Thermo Fisher Completes Acquisition of Purification & Filtration Business of Solventum for About $4B in Cash >TMO

2 sep 2025, 12:00 UTC

Acquisities, Fusies, Overnames

Solventum Completes Sale of Purification & Filtration Business to Thermo Fisher Scientific >SOLV TMO

23 jul 2025, 10:00 UTC

Winsten

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23 jul 2025, 10:00 UTC

Winsten

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23 jul 2025, 10:00 UTC

Winsten

Thermo Fisher 2Q Net $1.62B >TMO

23 jul 2025, 10:00 UTC

Winsten

Thermo Fisher 2Q EPS $4.28 >TMO

23 jul 2025, 10:00 UTC

Winsten

Thermo Fisher 2Q Rev $10.85B >TMO

14 jul 2025, 16:12 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 jul 2025, 15:06 UTC

Acquisities, Fusies, Overnames

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

28 mei 2025, 13:47 UTC

Acquisities, Fusies, Overnames

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

23 apr 2025, 10:01 UTC

Winsten

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23 apr 2025, 10:00 UTC

Winsten

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 apr 2025, 10:00 UTC

Winsten

Thermo Fisher 1Q EPS $3.98 >TMO

Peer Vergelijking

Prijswijziging

Thermo Fisher Scientific Inc Prognose

Koersdoel

By TipRanks

10.37% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 615.44 USD  10.37%

Hoogste 675 USD

Laagste 561 USD

Gebaseerd op 20 Wall Street-analisten die 12-maands prijsdoelen bieden voor Thermo Fisher Scientific Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

20 ratings

17

Buy

3

Hold

0

Sell

Technische score

By Trading Central

406.5 / 417.79Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Strong Bearish Evidence

Sentiment

By Acuity

74 / 373 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat